Skip to main content

prescription digital therapeutics

By Bradley Merrill Thompson | 12:11 pm | December 20, 2021
Healthcare professionals other than physicians, dentists and veterinarians who have prescribing authority under state law can order prescription digital therapeutics. That could improve access, especially to devices that treat mental health conditions.
By Laura Lovett | 02:55 pm | November 02, 2021
The study will focus on Type 2 diabetes patients. 
By Mallory Hackett | 03:46 pm | July 28, 2021
The funding brings MedRhythms total amount raised to $34 million since its inception.   
By Dave Muoio | 02:12 pm | March 01, 2021
The investment from "a leading national Integrated Delivery Network" brings the Series D's total to $100 million.
By Dave Muoio | 10:00 am | February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients. 
By Dave Muoio | 04:50 pm | February 12, 2021
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.
By Mallory Hackett | 12:46 pm | January 25, 2021
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine.   
By Dave Muoio | 04:50 pm | December 08, 2020
Mahana Therapeutics' Parallel is a three-month digital treatment that logs patients' symptoms to deliver relevant guidance and teach them condition-management skills.
By Dave Muoio | 01:14 pm | December 08, 2020
The company currently has three prescription digital therapeutics available on the market.
By Jonah Comstock | 11:54 am | September 10, 2020
Provider buy-in is more important than ever, digital therapeutics stakeholders say.